Clozapine attenuates the locomotor sensitisation and the prepulse inhibition deficit induced by a repeated oral administration of Catha edulis extract and cathinone in rats

Behavioural Brain Research

Volumn 160, Issue 2, 2005, Pages 365-373

  Banjaw, Mehret Yerdaw ^a   Fendt, Markus ^a   Schmidt, Werner J ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

5 Hydroxytryptamine; Dopamine; Locomotor sensitisation; Sensorimotor gating

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ATYPICAL ANTIPSYCHOTIC AGENT; CATHA EDULIS EXTRACT; CATHINONE; CLOZAPINE; DOPAMINE; NEUROTRANSMITTER; PSYCHOSTIMULANT AGENT; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; COMMERCIAL PHENOMENA; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DRUG REEXPOSURE; DRUG SENSITIZATION; DRUG WITHDRAWAL; EXPLORATORY BEHAVIOR; LOCOMOTION; MALE; METABOLITE; NEUROTOXICITY; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PREPULSE INHIBITION; PRIORITY JOURNAL; PROVOCATION TEST; RAT; SEROTONIN BRAIN LEVEL;

EID: 18044365588     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2005.01.002     Document Type: Article

References (59)

1. A. Alem, and T. Shibre Khat induced psychosis and its medico-legal implication: a case report Ethiop Med J 35 1997 137 139
2. M.P. Andersen, and B. Pouzet Effects of acute versus chronic treatment with typical or atypical antipsychotics on d-amphetamine-induced sensorimotor gating deficits in rats Psychopharmacology (Berl) 156 2001 291 304
3. L. Arseneault, M. Cannon, J. Witton, and R.M. Murray Causal association between cannabis and psychosis examination of the evidence Br J Psychiatry 184 2004 110 117
4. M. Awas, D. Kebede, and A. Alem Major mental disorders in Butajira, southern Ethiopia Acta Psychiatr Scand Suppl 397 1999 56 64
5. M.Y. Banjaw, and W.J. Schmidt Behavioural sensitisation following repeated intermittent oral administration of Catha edulis in rats Behav Brain Res 156 2005 181 189
6. R.L. Bell, Z.A. Rodd, C.C. Hsu, L. Lumeng, J.M. Murphy, and W.J. McBride Amphetamine-modified acoustic startle responding and prepulse inhibition in adult and adolescent alcohol-preferring and -nonpreferring rats Pharmcol Biochem Behav 75 1 2003 163 171
7. C.D. Blaha, and R.F. Lane Chronic treatment with classical and atypical antipsychotic drugs differentially decreases dopamine release in striatum and nucleus accumbens in vivo Neurosci Lett 78 1987 199 204
8. D.L. Braff, M.A. Geyer, and N.R. Swerdlow Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies Psychopharmacology 156 2001 234 258
9. D.J. Calcagnetti, and M.D. Schechter Increase in the locomotor activity of rats after intracerebral administration of cathione Brain Res Bull 29 1992 843 846
10. J.D. Connor, A. Rostom, and E. Makonnen Comparison of effects of khat extracts and amphetamine on motor behaviours in mice J Ethnopharmacol 81 2002 65 71
11. R. Depoortere, G. Perrault, and D.J. Sanger Potentiation of prepulse inhibition of the startle reflex in rats: pharmacological evaluation of the procedure as a model for detecting antipsychotic activity Psychopharmacology (Berl) 132 1997 366 374
12. D. Feifel, and K. Priebe The effects of repeated haloperidol on intact and dizocilpine-disrupted sensorimotor gating Psychopharmacology 146 1999 175 179
13. M. Fendt, L. Li, and J.S. Yeomans Brain stem circuits mediating prepulse inhibition of the startle reflex Psychopharmacology 156 2001 216 224
14. S. Ferre, and F. Artigas Clozapine decreases serotonin extracellular levels in the nucleus accumbens by a dopamine receptor-independent mechanism Neurosci Lett 187 1995 61 64
15. M. Filip, I. Papla, E. Nowak, and E. Przegalinski Blocking impact of clozapine on cocaine locomotor and sensitising effects in rats Pol J Pharmacol 55 2003 1125 1130
16. P. Gaszner, and Z. Makkos Clozapine maintenance therapy in schizophrenia Prog Neuropsychopharmacol Biol Psychiatry 28 2004 465 469
17. M.A. Geyer, K. Krebs-Thomson, D.L. Braff, and N.R. Swerdlow Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review Psychopharmacology 156 2001 117 154
18. X.M. Gao, T. Hashimoto, T.B. Cooper, and C.A. Tamminga The dose-response characteristics of rat oral dyskinesias with chronic haloperidol or clozapine administration J Neural Transm 104 1997 97 104
19. S.J. Graham, R.W. Langley, C.M. Bradshaw, and E. Szabadi Effects of haloperidol and clozapine on prepulse inhibition of the acoustic startle response and the N1/P2 auditory evoked potential in man J Psychopharmacol 15 2001 243 250
20. T.G. Heffner, J.A. Hartman, and L.S. Seiden A rapid method for the regional dissection of the rat brain Pharmacol Biochem Behav 13 1980 453 456
21. J. Ichikawa, and H.Y. Meltzer Relationship between dopaminergic and serotonergic neuronal activity in the frontal cortex and the action of typical and atypical antipsychotic drugs Eur Arch Psychiatry Clin Neurosci 249 1999 90 98
22. P. Kalix The pharmacology of psychoactive alkaloids from Ephedra and Catha J Ethnopharmacol 32 1991 201 208
23. P. Kalix The amphetamine-like releasing effect of the alkaloid (-)cathinone on rat nucleus accumbens and rabbit caudate nucleus Prog Neuropsychopharmacol Biol Psychiatry 6 1982 43 49
24. Y. Kebede Cigarette smoking and khat chewing among university instructors in Ethiopia East Afr Med J 79 2002 274 278
25. M. Koch, and M. Fendt Startle response modulation as a behavioural tool in neuropharmacology Curr Neuropharmacol 1 2003 175 185
26. V. Kumari, and T. Sharma Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: a critical evaluation of current evidence and directions for future research Psychopharmacology 162 2002 97 101
27. V. Kumari, W. Soni, and T. Sharma Normalization of information processing deficits in schizophrenia with clozapine Am J Psychiatry 156 1999 1046 1051
28. P. Laudrup, and L.J. Wallace Sensitisation elicited by directly and indirectly acting dopaminergic agonist: comparison using neural network analysis Psychopharmacology 141 1999 169 174
29. Z. Li, J. Ichikawa, and H.Y. Meltzer A comparison of the effect of loxapine with ziprasidone and thioridazine on the release of dopamine and acetylcholine in the prefrontal cortex and nucleus accumbens Psychopharmacology 167 2003 315 323
30. Y. Li, B. Kolb, and T. Robinson The location of persistent amphetamine-induced in the density of dendritic spines on medium spiny neurons in the nucleus accumbens and caudate-putamen Neuropsychopharmcology 28 2003 1082 1085
31. G.S. Linn, S.S. Negi, S.V. Gerum, and D.C. Javitt Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys Psychopharmacology (Berl) 169 2003 234 239
32. T. Mackeprang, K.T. Kristiansen, and B.Y. Glenthoj Effects of antipsychotics on prepulse inhibition of the startle response in drug-naive schizophrenic patients Biol Psychiatry 52 2002 863 873
33. C.K. Maitai, and M. Dhadphale Khat-induced paranoid psychosis Br J Psychiatry 152 1988 294
34. R.S. Mansbach, M.A. Geyer, and D.L. Braff Dopaminergic stimulation disrupts sensorimotor gating in the rat Psychopharmacology 2 1988 299 308
35. G.P. Mereu, C. Pacitti, and A. Argiolas Effect of (-)-cathinone, a khat leaf constituent, on dopaminergic firing and dopamine metabolism in the rat brain Life Sci 32 1983 1383 1389
36. E.J. Mylecharane, E. O'Rourke, and H.G. Lloyd Effects of acute and chronic treatment with clozapine on dopamine release in rat nucleus accumbens slice preparations Ann NY Acad Sci 861 1998 284 285
37. J.A. Nielsen Cathinone affects dopamine and 5-hydroxytryptamine neurons in vivo as measured by changes in metabolites and synthesis in four forebrain regions in the rat Neuropharmacology 24 1985 845 852
38. B. Oranje, C.J. Van Oel, C.C. Gispen-De Wied, M.N. Verbaten, and R.S. Kahn Effects of typical and atypical antipsychotics on the prepulse inhibition of the startle reflex in patients with schizophrenia J Clin Psychopharmacol 22 2002 359 365
39. K. Ossowska, M. Pietraszek, J. Wardas, M. Dziedzicka-Wasylewska, D. Nowicka, and S. Wolfarth Chronic treatments with haloperidol and clozapine alter the level of NMDA-R1 mRNA in the rat brain: an in situ hybridisation study Pol J Pharmacol 54 2002 1 9
40. A.M. Ouagazzal, F. Jenck, and J.L. Moreau Drug-induced potentiation of prepulse inhibition of acoustic startle reflex in mice: a model for detecting antipsychotic activity? Psychopharmacology 156 2001 273 283
41. E.A. Pehek, M.D. Schechter, and B.K. Yamamoto Effects of cathinone and amphetamine on the neurochemistry of dopamine in vivo Neuropharmacology 29 1990 1171 1176
42. R.C. Pierce, and P.W. Kalivas A circuitry model of the expression of locomotor sensitisation to amphetamine-like psychostimulants Brain Res Brain Res Rev 25 1997 192 216
43. M. Pietraszek, and K. Ossowska Chronic treatment with haloperidol diminishes the phencyclidine-induced sensorimotor gating deficit in rats Naunyn Schmiedebergs Arch Pharmacol 357 1998 466 471
44. B. Pouzet, M. Didriksen, and J. Arnt Effects of the 5-HAT 7 receptor antagonist SB-258741 in animal models for schizophrenia Pharmacol Biochem Behav 71 2002 655 665
45. R.J. Ralph, G.B. Varty, M.A. Kelly, Y.M. Wang, M.G. Caron, and M. Rubinstein The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice J Neurosci 19 1999 4627 4633
46. T.E. Robinson, and J.B. Becker Enduring changes in brain and behaviour produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis Brain Res 11 1986 157 198
47. R.B. Rothman, N. Vu, J.S. Partilla, B.L. Roth, S.J. Hufeisen, and B.A. Compton-Toth In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates J Pharmacol Exp Ther 307 2003 138 145
48. M.D. Schechter Dopaminergic nature of acute cathine tolerance Pharmacol Biochem Behav 36 1990 817 820
49. S.G. Selassie, and A. Gebre Rapid assessment of drug abuse in Ethiopia Bull Narc 48 1996 53 63
50. T.L. Sills Amphetamine dose dependently disrupts prepulse inhibition of the acoustic startle response in rats within a narrow time window Brain Res Bull 48 1999 445 448
51. S. Semenova, and A. Markou Clozapine treatment attenuated somatic and affective signs of nicotine and amphetamine withdrawal in subsets of rats exhibiting hyposensitivity to the initial effects of clozapine Biol Psychiatry 54 2003 1249 1264
52. J. Stewart, and A. Badiani Tolerance and sensitisation to the behavioural effects of drugs Behav Pharmacol 4 1993 289 312
53. N.R. Swerdlow, D.L. Braff, N. Taaid, and M.A. Geyer Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients Arch Gen Psychiatry 51 1994 139 154
54. N.R. Swerdlow, R.S. Mansbach, M.A. Geyer, L. Pulvirenti, G.F. Koob, and D.L. Braff Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine Psychopharmacology (Berl) 100 1990 413 416
55. S.W. Toennes, S. Harder, M. Schramm, C. Niess, and G.F. Kauert Pharmacokinetics of cathinone, cathine and norephedrine after the chewing of khat leaves Br J Clin Pharmacol 56 2003 125 130
56. T.M. Tzchentke, and W.J. Schmidt Blockade of locomotor sensitisation by MK-801: fact or artificat? A review of preclinical data Psychopharmacology 151 2000 141 151
57. L.J. Vanderschuren, E.D. Schmidt, T.J. De Vries, C.A. Van Moorsel, F.J. Tilders, and A.N. Schoffelmeer A single exposure to amphetamine is sufficient to induces long lasting behavioral, neuroendocrine, and neurochemical sensitisation in rats J Neursci 19 1999 9579 9586
58. P. Widler, K. Mathys, R. Brenneisen, P. Kalix, and H.U. Fisch Pharmacodynamics and pharmacokinetics of khat: a controlled study Clin Pharmacol Ther 55 1994 556 562
59. J. Zhang, J.A. Engel, B. Soderpalm, and L. Svensson Repeated administration of amphetamine induces sensitisation to its disruptive effect on prepulse inhibition in the rat Psychopharmacology (Berl) 135 1998 401 406